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Abstract
Background: Fine needle aspiration cytology (FNAC) forms one of the first diagnostic tools in
the evaluation of tumors. Its role in diagnosing soft tissue tumors (STT) has been fairly documented,
as well as debated. Present study was aimed at evaluating its scope in diagnosing 127 cases of soft
tissue tumors.
Methods: Conventional Pap and MGG staining was available in all the cases. Immunocytochemistry
(ICC) was performed in 15 cases. Histopathological details were available in 115 cases.
Results: 50% cases were referred for a primary diagnosis, while 26.8% & 22.8% cases were
evaluated for recurrent and metastatic lesions, respectively. Extremities were the commonest sites.
On FNAC, 101 cases (79.5%) were labeled as malignant, whereas 10 cases (7.9%) were labeled as
benign. The remaining 16 cases (11%) were not categorized and were labeled as 'unsure/not
specified'. Histopathological confirmation in 115 cases, gave a diagnostic accuracy of 98%, with a
positive predictive value of 98% in malignant cases and a negative predictive value of 100% in benign
cases. Two cases were false positive. Among the various cytological categories, 60 cases (47.2%)
were of spindle cell type, followed by 32 (25.2%) of round cell type and 14 cases (11%) of
lipomatous type. Other 12 cases (9.4%) were of pleomorphic type; 7 (5.5%) cases of epithelioid
type and remaining 2 cases were of myxoid type. All the round cell, pleomorphic and myxoid type
of tumors were sarcomas, whereas 73.3% cases of spindle cell type were labeled as 'malignant'.
Exact cytological sub typing was offered in 58 cases, with rhabdomyosarcoma (RMS) as the most
frequently sub typed tumor. The two false positive malignant cases were of fibromatosis and a
pigmented schwannoma, on biopsy. Out of 28 metastatic lesions, lymph nodes were the
commonest site for metastasis, with epithelioid tumors that formed highest percentage of
metastatic cases.
Conclusion: FNAC is fairly specific and sensitive in STT diagnoses for primary, recurrent and
metastatic lesions. The cytological types, especially round cell and pleomorphic sarcomas, can be
quickly identified. Clinicopathological correlation with ICC as an adjunct, are valuable in exact sub
typing.
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Background
Soft tissue tumors (STT) are rare neoplasms. At our hospi-
tal, 2.5% of the cancer cases are constituted by soft tissue
sarcomas. Most of these cases are referrals, including a
larger proportion of malignant cases, invariably with a
high grade and stage. [1] These tumors pose a significant
diagnostic challenge as a result of their morphologic over-
lap and biological heterogeneity [2]. Among its various
diagnostic aids, lately, FNAC has been gaining importance
as a result of its cheap cost, easy performance, safety,
along with fair specificity and specificity, especially in
terms of sorting out malignant cases. Apart from its use in
recurrent and metastatic cases, FNAC has been identified
as a useful diagnostic technique in the initial diagnosis of
STTs [3-8].
The present study was aimed at evaluating 127 cases of
FNAC smears from soft tissue tumors, diagnosed over a
period of 5 years. The other objectives included identifica-
tion of cyto-histological concordance in terms of malig-
nancy; stratification of the tumors into various
cytomorphological categories and to note the extent of
specific sub-typing in individual cases.
Methods
127 aspirates (unaided and guided) from STTs were eval-
uated over a period of 5 years (2001–2006). Only cases
with relevant clinical data were included. All cases
included conventional Papanicolaou (Pap) and May
Grunwald Giemsa (MGG) stained smears. Inadequate
smears were the ones with 'no' or scanty cells. Non-neo-
plastic lesions, on biopsy, were excluded. Histological
details, in 115 cases, were accessed from the clinical charts
and the Hospital Diagnostic Information System (DIS).
On examination, all cases were placed into 6 cytomorpho-
logical categories, namely spindle cell, round cell, pleo-
morphic, myxoid, epithelioid/polygonal cell and
lipomatous type [9]. In cases of mixed components, the
specific subtype was assigned based on the predominant
morphological pattern. Immunocytochemistry was per-
formed in 15 cases for an exact sub typing, on smears and
cell blocks. Exact sub typing was offered in the clinical
context, with ICC as an adjunct.
Immunocytochemistry (ICC) technique on smears
Smears were fixed in methanol, followed by 3 changes in
100% absolute alcohol for 5 min each. This was followed
by washing under running tap water for 5 min. Next, the
smears were subjected to endogenous peroxidase for 30
min (H2O2 + methanol). This was followed by washing
under running tap water, antigen retrieval (low heat with
microwave or enzyme) and 3 changes of wash with Tris
Buffer solution (TBS) ~5 min. Subsequently, blocking
serum was applied, followed by incubation with primary
antibody ~1 hour and TBS washing. Further, secondary
antibody was applied for 30 min, followed by washing
with TBS and application of avidin-biotin complex (ABC).
Afterwards, TBS washing was carried out with subsequent
staining with Diamino Benzidine (DAB) reagent. Harris'
hematoxylin was used as a counter stain. Finally, the
smears were dehydrated with absolute alcohol, cleared
with xylene and mounted with DPX. The cases were
accompanied with appropriate controls. A limited panel
of markers was carried out on the smears, including
vimentin, desmin, S-100, cytokeratin (CK), MIC-2, myo-
genin, neuron specific enolase (NSE), synaptophysin,
chromogranin and myeloperoxidase (MPO).
Immunohistochemistry (IHC) was performed by immu-
noperoxidase procedure. On biopsy a wide panel of mark-
ers was carried out for exact subtyping. In addition,
smooth muscle actin (SMA), Myo D-1, BCL-2, epithelial
membrane antigen (EMA), Leukocyte common antigen
(LCA),  ALK-1, CD30, NSE, synaptophysin and chrom-
ogranin (Dako, Produkionsveg, Glostrup, Denmark) con-
stituted as other markers.
Statistical analysis
Statistical analysis was carried out using SPSS (version 14)
software. Descriptive analysis was performed using fre-
quency and percentages. In terms of malignancy, cytology
was compared with histopathological findings by calcu-
lating specificity, sensitivity, and concordance along with
positive and negative predictive values (PV). The signifi-
cance of various cytological categories in terms of benign,
malignant and 'unsure'/not specified' was analyzed using
chi-square test. P value < 0.05 was considered significant.
Results
Out of 127 cases, maximum cases (27, 21.3%) were noted
in the age group 21–30 years. Lower extremities were the
common sites, with thigh as the most common site of
occurrence in 20 cases (15.7%). Males outnumbered the
females (1.8:1).
Sixty-four cases (50.4%) were referred for a primary diag-
nosis, while 34 cases (26.8%) were evaluated for recurrent
lesions & remaining 29 cases (22.8%) cases for metastatic
disease.
On FNAC, 101 cases (79.5%) were labeled as malignant
and 10 cases (7.9%) as benign. 16 cases (14.5%) were
labeled as 'unsure'/'not categorized'. With biopsy results,
finally, 107 cases (84.25%) were labeled malignant/sarco-
mas; 16 (12.59%) as benign, 2 as borderline/intermediate
malignancies and 2 cases were 'unsure/not specified'. His-
topathological confirmation, available in 115 cases
(90.5%), gave a diagnostic accuracy of 98% with a posi-
tive predictive value of 98% in terms of malignancy and aCytoJournal 2007, 4:20 http://www.cytojournal.com/content/4/1/20
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negative predictive value of 100% in benign cases. The
overall sensitivity was 100% and specificity was 83.3%.
Out of the 16 cases that were not categorized, 5 turned out
to be benign, 8 malignant and 2 cases as intermediate
malignancy, on histopathology. The remaining 2 cases
lacked biopsy results.
Among the various cytomorphological categories, 14
cases (11%) were of lipomatous tumors, 12 cases (9.4%)
were of pleomorphic type, 32 cases (25.2%) were of
round cell type, 60 (47.2%) of spindle cell type, 7 cases
(5.5%) of epithelioid type and the remaining 2 cases were
of myxoid type. All the round cell, epithelioid, pleomor-
phic and myxoid tumors were sarcomas. Out of 60 cases
of spindle cell subtype, 44 (73.3%) were malignant and
16 cases (26.6%) were not categorized, either as benign or
malignant.
The cytological diagnoses included 'terms' like spindle cell
sarcoma (31 cases), malignant round cell tumor (12
cases), sarcoma of epithelioid type (7 cases), spindle cell
tumor (14 cases), and spindle cell lesion (4 cases). Ten
benign cases were of lipomas.
Out of 16 'unsure'/'non classified' cases; on biopsy, 8
cases turned out to be malignant, namely 3 spindle cell
sarcomas, 2 MPNSTs, 1 synovial sarcoma, 1 gastrointesti-
nal stromal tumor (GIST) and 1 pleomorphic sarcoma
(NOS). The remaining 8 cases included 2 of intermediate
malignancy, namely, 1 case, each of a dermatofibrosar-
coma protuberans (DFSP) and fibromatosis. Another 1
case was of proliferative fasciits. Another 3 cases included
2 of schwannoma and 1 case of a neurofibroma. Remain-
ing 2 cases could not be categorized due to lack of biopsy
results
With the help of clinical details and ICC, exact sub typing
was possible in 58 cases. Out of 14 lipomatous tumors,
commonest were lipomas (10 cases), including 1 case of a
pleomorphic lipoma; 2 cases were of myxoid liposarco-
mas and remaining 2 cases were of pleomorphic liposar-
comas. Out of 60 cases of spindle cell category, specific
diagnoses in 14 cases included leiomyosarcoma (3 cases),
MPNST (2 cases), synovial sarcoma (3 cases), melanoma
of soft parts (1 case). One case was offered a differential
diagnosis of MPNST vs. melanoma of soft parts, another
of a MPNST vs. synovial sarcoma and remaining 1 case
was of sarcoma vs. a sarcomatoid carcinoma (poorly dif-
ferentiated). In the round cell category, exact sub typing
was more possible i.e. in 20 cases that included RMS (10
cases), PNET/Ewing's (9 cases) along with 1 case of a neu-
roblastoma. In the pleomorphic group, 8 cases were
labeled as pleomorphic cell sarcoma, 2 as pleomorphic
rhabdomyosarcomas and 1 case as an extraskeletal oste-
osarcoma. One case was offered a differential of a pleo-
morphic sarcoma vs. poorly differentiated carcinoma,
however, lacked biopsy results.
Out of 7 cases of tumors with epithelioid morphology, all
were malignant. The cytological diagnoses included 1 case
of an epithelioid sarcoma and 1 case of an epithelioid
MPNST. Remaining 5 cases were labeled as sarcomas with
an epithelioid morphology. On histopathology, 1 of these
turned out as a malignant granular cell tumor; 1 epithe-
lioid leiomyosarcoma; 1 Alk1 positive anaplastic large cell
lymphoma (ALCL) and another 1 as a pleomorphic sar-
coma (NOS). One case turned out to be a myxoid liposa-
rcoma with round/polygonal cells, the latter that were
seen in the smears. In the myxoid category, both the
tumors were designated as myxofibrosarcomas. (Figures
1, 2, 3, 4). While one of these was in the thigh of a 60 years
old male, the other case that turned out as a pleomorphic
sarcoma, myxoinflammatory type on biopsy, was identi-
fied in the leg of a 52 years old male. (Table No. 1, 2, 3, 4)
Twenty-eight cases (22%) presented with metastatic
deposits, commonly in lymph nodes (16 cases, 57.1%),
followed by liver and lungs as the next commonest sites.
Highest numbers of cases revealing metastatic deposits
A. Pleomorphic lipoma. Mature adipose tissue fragments with  giant cells (arrow) Figure 1
A. Pleomorphic lipoma. Mature adipose tissue fragments with 
giant cells (arrow). MGG × 200. B. High power view of 'Flo-
ret-type' giant cells, displaying 'wreath-like' nuclear arrange-
ment. MGG × 400. C. Biopsy of pleomorphic lipoma 
displaying floret-type giant cells. H&E × 200. D. Myxoid 
Liposarcoma. Abundant metachromatic, myxoid stroma with 
vacuolated cells (Lipoblasts) (arrow). MGG × 400. E. Cellular 
smear showing plexiform capillary network with entrapped 
lipoblasts (inset) Pap × 200. F. Pleomorphic liposarcoma. 
Hypercellular smear showing several pleomorphic cells 
(arrow), including lipoblasts admixed with inflammatory cells. 
Pap × 400.CytoJournal 2007, 4:20 http://www.cytojournal.com/content/4/1/20
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were of spindle cell type. However, the highest percentage
of cases was of epithelioid category (28.5%), followed by
pleomorphic (25.5%), spindle cell (25%), round cell cat-
egory (18.75%) and finally; lipomatous tumors (14.2%).
In terms of exact subtypes, RMS (6 cases) was the com-
monest tumor to metastasize, followed by leiomyosar-
coma (5 cases), synovial sarcoma (4 cases) and
pleomorphic sarcoma (4 cases).
Discussion
Soft tissue tumors (STTs) have been diagnosed with the
'time-honored' histopathology that is recognized as the
'gold standard' for their evaluation. However, in the cur-
rent era, where 'needle is preceding the scalpel' and the
biopsy material is getting limited, it would be prudent to
discuss the role and scope of FNAC in diagnosing STTs.
The role of FNAC has mostly been noted in soughting
recurrent and metastatic STT cases [6-8]. Nevertheless,
there are studies indicating its role in primary diagnosis of
these tumors [3-5]. The present study was carried out to
highlight various aspects of cytological diagnosis of STTs,
in a series of 127 cases, wherein maximum cases (50%)
were submitted exclusively for a primary diagnosis. An
increased number of overall malignant (84.25%) vs.
benign cases (12.5%) in our series were comparable to a
study by Miralles et al [10] and contrasting to another
other study [11]. The reason was the predominance of
referral cases, including a greater proportion of sarcomas
that our center receives. Moreover, non-neoplastic lesions
were excluded in this study.
A. Malignant peripheral nerve sheath tumor Figure 3
A. Malignant peripheral nerve sheath tumor. Hypercellular 
smear showing loosely cohesive spindly cells with indented, 
'serpentine' nuclei Pap × 400. B. Tumor cells showing S-100 
positivity on cellblock preparation. DAB × 400. C. Leiomy-
osarcoma. Hypercellular smear showing fragments and singly 
scattered cells with blunt-ended nuclei. Pap × 400. D. 
Endometrial stromal sarcoma (ascertained on biopsy). 
Hypercellular smear with ovoid cells and abundant meta-
chromatic basement membrane material. MGG × 200. F. Syn-
ovial sarcoma. Hypercellular smear with oval to elongated 
cells exhibiting overlapping. Pap × 200. G. A recurrent syno-
vial sarcoma showing biphasic cellular pattern and eosi-
nophilic material on smears. MGG × 400. H. Melanoma of 
soft parts. Cellular smear with spindly cells displaying promi-
nent nucleolisation (inset). Pap × 400. I. Strong S-100 positiv-
ity on smears. DAB × 400 (Inset, S-100 highlighting spindly 
processes. DAB × 1000). J. Myxofibrosarcoma. Moderately 
cellular smear with oval cells admixed with metachromatic 
myxoid stroma. MGG × 200. K. Curvilinear vascular pattern 
with cells around. MGG × 400. L. Pleomorphic Rhabdomy-
osarcoma. Hypercellular smear with markedly pleomorphic 
cells. Pap × 400. Inset showing a pleomorphic rhabdomyob-
lastic cell. Pap × 400. M. Pleomorphic sarcoma not otherwise 
specified (NOS). Hypercellular smear with markedly pleo-
morphic cells against a hemorrhagic background. MGG × 
400.
A. Rhabdomyosarcoma (RMS). Hypercellular smear with  round cells, including plasmacytoid and binucleate forms  (arrow), against a 'lacy' background MGG × 200 Figure 2
A. Rhabdomyosarcoma (RMS). Hypercellular smear with 
round cells, including plasmacytoid and binucleate forms 
(arrow), against a 'lacy' background MGG × 200. B. Smear 
with singly scattered round cells and an isolated strap cell/
tumor rhabdomyoblast (arrow). Pap × 200. C. Diffuse 
desmin positivity in the round cells. DAB × 400. D. Alveolar 
RMS. Hypercellular smear with round cells including 
'wreath'-like giant cells (inset). Pap × 400. E. High power view 
of an isolated wreath-like giant cell. Pap × 400. F. Cell block 
preparation showing strong myogenin expression. DAB × 
400. G. PNET. Hypercellular smear with round cells, scat-
tered singly and forming 'rosettes' (arrow). H. Positive MIC2 
(CD99) expression in the tumor cells (DAB × 400). I. Neu-
roblastoma. Smear displaying round cells, with fine nuclear 
chromatin and exhibiting Homer-wright rosettes. J. High 
power view of an isolated pseudo rosette. L. Granulocytic 
sarcoma (formed on biopsy). Malignant round cell tumor, 
showing blasts. Strong MP0 positivity, on imprint, in the 
tumor cells. (DAB × 200).CytoJournal 2007, 4:20 http://www.cytojournal.com/content/4/1/20
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In terms of diagnosis, complex heterogeneity of STTs is
known to be a limiting factor in their exact categorization.
With the advent of ancillary techniques like IHC, flow
cytometry, cytogenetics and molecular techniques, the
objectivity of diagnosing a STT has been considerably
enhanced. In a study, Kilpatrick et al [4] have presented
the extent to which cytology can be utilized in effective
diagnosis of STTs. Subsequently, there have been studies
highlighting application of the ancillary techniques in
exact sub typing of these tumors [7,8,12,13]. Apart from
providing material for these studies, FNAC is easy, safe
and cost effective. While the fear of tumor seedling is
hardly noted, its effectivity is best exemplified with more
access to mass lesions in form of multiple aspirates [4]. In
our series, none of the cases had complications or tumor
seedlings.
In terms of diagnostic efficacy, 100% sensitivity and 87%
specificity in our cases was comparable to results of Nagira
et al [11], wherein the respective values were 92% and
97% respectively. In another series, Wakely et al [14]
reported 100% sensitivity and 97% specificity in STT diag-
nosis with FNAC. Layfield et al [3] achieved 95% sensitiv-
ity and specificity while dealing with these lesions. In our
study, 2 cases (1.57%) were false positive (FP) and none
was false negative (FN). While a study on 517 STT aspi-
rates by Akerman et al [15] revealed a 2.9% false positive
rate, the subsequent studies by Wakely et al [14] and by
Kilpatrick et al [4] yielded a single case of false negativity
and nil false positivity. This was in contrast to a study by
Nagira et al [11], who identified higher figures for false
positivity and false negativity. Our results were compara-
ble to the documented range of < 1%–5% (FP) and 2–
15% (FN) [3,4,11,16]. Nil FN in our series was due to the
fact that 16 cases were diagnosed as 'unsure'/not specified.
Out of these 8 turned out to be malignant, 1 of intermedi-
ate malignancy and 5 benign, on biopsy. An overall con-
cordance of 98% is comparable to results of Shah et al
[17].
A basic cytological approach towards making a STT diag-
nosis begins with the familiarity with normal structures,
along with myxoid or metachromatic stromal fragments
and a variety of dyscohesive cells like spindly, round, ple-
omorphic, polygonal that are indicators of a STT, on aspi-
rates [9,18]. These features are integrated with clinico
radiological findings. The value of radiological findings
has been fairly discussed [11,19]. Infact, improved locali-
zation of the ST lesion with radiological techniques has
revolutionized the amount of aspirate one can achieve,
especially in deep-seated lesions. An adequate aspirate is
analyzed and non-neoplastic lesions are sorted out. This is
followed by placing neoplastic lesions in benign, border-
line/intermediate and malignant groups. This approach
was followed in the present study, with the exclusion of
secondary soft tissue deposits of carcinomas. The sarco-
mas were not graded similar to a study by Nagira et al
[11], even though attempts at cytologic grading of sarco-
mas have been made [20]. In their study, Mathur et al [20]
identified a low concordance of cytological grading in
cases of grade 1 vs. high-grade sarcomas. Our series
focused upon the value of cytomorphological sub typing
into the six categories, as noted earlier [9,11]. While all 32
cases of round cell category; 7 of epithelioid type; 12 of
pleomorphic type and 2 of myxoid type were placed into
malignant groups, 44 of the total 60 cases (73.3%) of
spindle cell type could be labeled as sarcomas. Of the
remaining 16 cases, 8 turned out to be malignant; 2 of
borderline malignancy and 4 as benign. Remaining 2
cases could not be ascertained, in view of lack of biopsy
results. The relationship between cytological categoriza-
tion with benignancy or malignancy of the subtypes was
statistically significant. Among the lipomatous group,
more cases (10/14) were benign than malignant (4/14).
(p < 0.05). While the results for round cell, pleomorphic
and lipomatous tumors were comparable to the findings
of Nagira et al [11]; we observed more cases of spindle and
all of polygonal and myxoid types, as malignant. The rea-
sons include referral of mostly malignant cases to our cen-
tre.
Tumors with epithelioid/polygonal shapes, exactly catego- rized on biopsy Figure 4
Tumors with epithelioid/polygonal shapes, exactly catego-
rized on biopsy. A. Epithelioid sarcoma (recurrent case). 
Hypercellular smear with polygonal cells, scattered singly, 
displaying fine vacuoles in a minority of cells (inset). Pap × 
400. B. Anaplastic large cell lymphoma. Hypercellular smear 
with singly scattered cells revealing moderate to abundant, 
eosinophilic to finely vacuolated cytoplasm and pleomorphic 
nuclei. MGG × 400. C. Malignant granular cell tumor. Hyper-
cellular smear with loosely cohesive and singly scattered cells 
exhibiting ovoid nuclei and abundant, granular, eosinophilic 
cytoplasm. Pap × 200. C. Diffuse S-100 positivity in tumor 
cells on IHC on biopsy. DAB × 200.CytoJournal 2007, 4:20 http://www.cytojournal.com/content/4/1/20
Page 6 of 10
(page number not for citation purposes)
Table 1: Various cases of spindle cell tumors with FNAC and histopathologic diagnoses
Sr No. Age Gender Site FNAC Diagnosis Histopathology Diagnosis Concordance
1 43 M Thigh Spindle cell sarcoma Synovial sarcoma 1
2 30 M Thigh Spindle cell sarcoma Synovial sarcoma 1
3 62 F Retroperitoneum Spindle cell sarcoma NK 3
4 55 F Chest wall Spindle cell sarcoma NK 3
5 65 M Retroperitoneum Spindle cell sarcoma NK 3
6 64 M Axilla Spindle cell sarcoma NK 3
7 56 M Leg Spindle cell sarcoma Spindle cell sarcoma 1
8 57 M Retroperitoneum Spindle cell sarcoma Spindle cell sarcoma 1
9 21 M Skull Spindle cell sarcoma MPNST 1
10 34 F Iliac Fossa Spindle cell sarcoma NK 3
11 29 M Heel Synovial sarcoma Synovial sarcoma 1
12 27 F Uterus Leiomyosarcoma endometrial stromal sarcoma 1
13 56 M Abdominal wall Spindle cell tumor Spindle cell sarcoma 2
14 26 M Arm Spindle cell tumor MPNST 2
15 54 M Iliac Fossa Spindle cell tumor GIST 2
16 48 M Neck Leiomyosarcoma Leiomyosarcoma 1
17 37 M Pleura Spindle cell tumor Schwannoma 2
18 50 M Posterior Mediastinum MPNST MPNST 1
19 62 M Forearm Spindle cell tumor-Neurogenic MPNST 2
20 48 F Uterus Spindle cell sarcoma Leiomyosarcoma 1
21 40 F Intra abdominal Spindle cell tumor NK 3
22 50 F Uterus Sarcoma vs poorly differentiated carcinoma Leiomyosarcoma 1
232 50 F Uterus Leiomyosarcoma Leiomyosarcoma 1
4 34 M Paraspinal Melanoma vs MPNST Pigmented schwannoma 4
25 51 M Intra abdominal Spindle cell tumor DFSP 2
26 25 F Lumbar MPNST MPNST 1
27 25 M Iliac Fossa Spindle cell sarcoma NK 3
28 51 M Arm Spindle cell tumor Proliferative Fascitis 2
29 40 M Heel Clear cell sarcoma/Melanoma Clear cell sarcoma/Melanoma 1
30 52 F Leg Synovial sarcoma Synovial sarcoma 1
31 66 M Suprascapular Spindle cell sarcoma Spindle cell sarcoma 1
32 51 M Arm Spindle cell sarcoma Leiomyosarcoma 1
33 66 M Neck Spindle cell tumor NK 3
34 29 F Ovary Spindle cell sarcoma Spindle cell sarcoma 1
35 22 F Intra abdominal Spindle cell lesion Fibromatosis 2
36 22 M Maxilla Spindle cell sarcoma MPNST 1
37 68 M Foot Spindle cell sarcoma Spindle cell sarcoma 1
38 35 M Maxilla Spindle cell lesion Spindle cell sarcoma 2
Sr No. Age Gender Site FNAC Diagnosis Histopathology Diagnosis Concordance
39 35 F Thigh Spindle cell sarcoma Fibrosarcoma 1
40 39 F Thigh Spindle cell sarcoma Spindle cell sarcoma 1
41 35 F Thigh Spindle cell sarcoma Fibromatosis 4
42 28 F Scapula Spindle cell sarcoma: Synovial/vs MPNST Synovial sarcoma 1
43 47 M Occiput Spindle cell tumor Pleomorphic sarcoma 2
44 28 M Thorax Spindle cell lesion Neurofibroma 2
45 20 F Thigh Spindle cell sarcoma MPNST 1
46 40 M Thigh Spindle cell sarcoma Spindle cell sarcoma 1
47 32 F Neck Spindle cell sarcoma Spindle cell sarcoma 1
48 25 F Arm Spindle cell sarcoma Synovial sarcoma 1
49 55 F Lung Spindle cell tumor Spindle cell tumor 1
50 13 M Leg Spindle cell sarcoma MPNST 1
51 30 M knee Synovial sarcoma Synovial sarcoma 1
52 32 M Neck Spindle cell sarcoma Synovial sarcoma 1
53 30 F Neck Spindle cell lesion Spindle cell sarcoma 2
54 24 F Poplitial Fossa Spindle cell tumor Synovial sarcoma 2
55 40 F Thigh Spindle cell sarcoma NK 3
56 56 M Leg Clear cell sarcoma/melanoma Clear cell sarcoma/melanoma 1
57 23 M Foot Spindle cell sarcoma Synovial sarcoma 1
58 67 M Neck Spindle cell sarcoma Spindle cell sarcoma 1
59 47 F Arm Spindle cell tumor Schwannoma 2
60 22 M Popliteal Fossa Spindle cell sarcoma MPNST 1
Key: Concordance: 1: Concordant; 2: Not specified; 3: Couldn't be ascertained; 4: Discordant M: Male, F: FemaleCytoJournal 2007, 4:20 http://www.cytojournal.com/content/4/1/20
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In terms of exact sub typing, which was offered in 58
cases, all lipomatous and 70% pleomorphic tumors were
suitably categorized. One case of a pleomorphic lipoma
showed presence of mature fibroadipose fragments with
'floret-like' giant cells, displaying nuclear molding. Pres-
ence of this tumor in a superficial location i.e. neck, in an
elderly male, was a helpful clue in ruling out a liposar-
coma [21]. 70% of pleomorphic sarcomas were catego-
rized in congruence with histopathology. Four out of 10
cases could not be categorized, even on histology with
IHC. The reason is the referral of poorly differentiated sar-
comas to our center. In their study, Berardo et al [22] con-
cluded lack of any cytological features that could
differentiate between malignant fibrous histiocytomas
with other pleomorphic sarcomas.
Table 2: Various cases of round cell tumors with FNAC and histopathologic diagnoses
Sr No. Age Gender Site FNAC Diagnosis Histopathology Diagnosis Concordance
1 2 M Orbit Rhabdomyosarcoma Rhabdomyosarcoma 1
2 14 M Hand Rhabdomyosarcoma Rhabdomyosarcoma 1
3 11 M Chest wall Round cell sarcoma Rhabdomyosarcoma 1
4 18 F Orbit Rhabdomyosarcoma Rhabdomyosarcoma 1
5 2 M Thigh PNET/Ewing's sarcoma PNET/Ewing's sarcoma 1
6 27 M Thigh PNET/Ewing's sarcoma PNET/Ewing's sarcoma 1
7 25 M Iliac Fossa PNET/Ewing's sarcoma PNET/Ewing's sarcoma 1
8 25 M Iliac Fossa PNET/Ewing's sarcoma PNET/Ewing's sarcoma 1
9 30 F Neck Sarcoma – Epithelioid PNET/Ewing's sarcoma 1
10 19 M Thigh Malignant round cell tumor PNET/Ewing's sarcoma 1
11 46 F Neck Malignant round cell tumor PNET/Ewing's sarcoma 1
12 5 F Thigh Rhabdomyosarcoma Rhabdomyosarcoma 1
13 16 M Maxilla Rhabdomyosarcoma Rhabdomyosarcoma 1
14 17 F Thigh Rhabdomyosarcoma Rhabdomyosarcoma 1
15 18 M Scalp Rhabdomyosarcoma Rhabdomyosarcoma 1
16 3 M Leg Rhabdomyosarcoma Rhabdomyosarcoma 1
17 19 M Neck Rhabdomyosarcoma Rhabdomyosarcoma 1
18 1 M Paraspinal Round cell sarcoma Rhabdomyosarcoma 1
19 30 F Gluteal PNET/Ewing's sarcoma PNET/Ewing's sarcoma 1
20 5 F Scapula Malignant round cell tumor Neuroblastoma 1
21 8 M Leg Malignant round cell tumor Rhabdomyosarcoma 1
22 9 M Intra abdominal Malignant round cell tumor Rhabdomyosarcoma 1
23 2 M Orbit Malignant round cell tumor Retinoblastoma 1
24 3 M Gluteal Round cell sarcoma NK 3
25 4 F Chest wall PNET/Ewing's sarcoma PNET/Ewing's sarcoma 1
26 1 F Orbit Neuroblastoma Neuroblastoma 1
27 22 M Scalp Malignant round cell tumor Granulocytic sarcoma 1
28 13 M Chest wall PNET/Ewing's sarcoma PNET/Ewing's sarcoma 1
29 20 F Axilla PNET/Ewing's sarcoma PNET/Ewing's sarcoma 1
30 35 M Iliac Fossa PNET/Ewing's sarcoma PNET/Ewing's sarcoma 1
31 16 M Iliac Fossa Malignant round cell tumor DSRCT 1
32 6 F Maxilla Rhabdomyosarcoma (alveolar) Rhabdomyosarcoma (alveolar) 1
Key: Concordance: 1: Concordant; 2: Not specified; 3: Couldn't be ascertained; 4: Discordant M: Male, F: Female
Table 3: Various cases of epithelioid tumors with FNAC and histopathologic diagnoses
Sr No. Age Gender Site FNAC Diagnosis Histopathology Diagnosis Concordance
1 68 M Back Epithelioid sarcoma Epithelioid sarcoma 3
2 47 M Thigh Epithelioid MPNST Epithelioid MPNST 1
3 28 M Leg Sarcoma – Epithelioid Leiomyosarcoma 1
4 58 F Thigh Sarcoma – Epithelioid Myxoid liposarcoma 1
5 65 M Shoulder Sarcoma – Epithelioid Pleomorphic sarcoma (NOS) 1
6 43 M Thigh Sarcoma – Epithelioid Malignant Granular cell tumor 1
7 16 M Elbow Sarcoma – Epithelioid Anaplastic Large cell Lymphoma 1
Key: Concordance: 1: Concordant; 2: Not specified; 3: Couldn't be ascertained; 4: Discordant M: Male, F: FemaleCytoJournal 2007, 4:20 http://www.cytojournal.com/content/4/1/20
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Further, 21 cases of round cell tumors, 13 of spindle cell
tumors; 2 cases of myxoid type and 2 cases of epithelioid
type were ascertained an exact subtype. Maximum cases in
the round cell group were of rhabdomyosarcoma and
PNET/Ewing's. These diagnoses were confirmed with
desmin positivity in the former and CD99 positivity in
few of the latter cases. One case of an RMS, with an alveo-
lar component, was formed in view of presence of several
'wreath-like' giant cells. This was confirmed with positive
desmin and myogenin staining on ICC, along with posi-
tive Myo-D1 expression, on IHC. Further, positive PAX3-
FKHR analysis confirmed the alveolar component [23].
One case of soft tissue neuroblastomas showed neuropils
and false rosettes. This was objectively confirmed with
NSE positivity and MIC2 negativity. Neuroblastomas were
lesser in number in our study, as these tumors are well
diagnosed with imaging findings, biochemical tests and
biopsy, at our Center. FNAC was carried out in few cases.
Among spindle cell tumors, specific diagnoses were
assigned in few cases viz. leiomyosarcoma, MPNST, syno-
vial sarcoma in 3 cases and melanoma in 1 case. While the
former 2 were substantiated with clinical details, includ-
ing location, synovial sarcoma was diagnosed based on
specific cytomorphological features. Diagnosis of synovial
sarcoma in 3 cases included 2 metastatic cases and one
recurrent case. Cytomorphology of synovial sarcoma on
cytology is complex. In unusual situations, ICC and t (x:
18) translocations (SYT-SSX) can be useful in forming this
exact subtype [13,24]. One case of melanoma of soft parts
was ascertained with prominently nucleolated spindly
cells and few polygonal cells that exhibited diffuse S-100
positivity. This was confirmed with additional HMB45
positivity, on IHC [25]. On biopsy, level of exact subyping
was significantly increased in spindle cell tumors. Another
case of an endometrial stromal sarcoma was presumed to
be a leiomyosarcoma, on FNAC. Retrospectively, presence
of hypercellular smears with ovoid cells and prominent
basement membrane-like material reminiscent of prolif-
erating vessels were identified as useful features. Recently,
a similar case has been reported [26]. Out of 16 cases that
were not classified, 4 turned out benign on biopsy. The
remaining 8 cases included 2 of intermediate malignancy,
namely, 1 case, each of a dermatofibrosarcoma protuber-
ans (DFSP) and fibromatosis. Another 1 case was of pro-
liferative fasciits, on biopsy. In case of adequate material
and typical clinical settings, diagnosis of a DFSP can be
suggested [27]. The other daunting tumor is fibromatosis
that is recognized as a pitfall in STT diagnosis [3,5,13].
This was identified as 1 false positive case in our study,
along with another case of MPNST that turned out to be a
pigmented schwannoma, on histopathology.
While 2 myxoid tumors were termed as myxofibrosarco-
mas, one of these turned out to be a pleomorphic sar-
coma, myxoinflammatory type. Lack of exact
categorization of sarcomas with epithelioid morphology
(5 cases) was due to limited cellularity and tumor hetero-
geneity. One case labeled as sarcoma with epithelioid
morphology turned out to be a myxoid liposarcoma, with
a round/polygonal cell component. The remaining 2 cases
in this category were unusual. While one case turned out
to be a malignant granular cell tumor, the other was an
Alk-1 positive ALCL. Granular cell tumors have been rec-
ognized as a pitfall in FNAC of breast lesions [28]. The
diagnosis was ascertained with S100 positivity, on biopsy
[29]. The case of an Alk1 + ALCL was noted in a young
adolescent male, with multifocal lesions Smears showed
dyscohesive polygonal cells with multilobated nuclei and
moderate amount of finely vacuolated cytoplasm [30].
Positivity for LCA, CD30, EMA and Alk-1 confirmed this
diagnosis, on biopsy. The morphological overlapping was
Table 4: Various cases of pleomorphic tumors with FNAC and histopathologic diagnoses
Sr No. Age Gender Site FNAC Diagnosis Histopathology Diagnosis Concordance
1 49 M Scapula Pleomorphic cell sarcoma Pleomorphic sarcoma (NOS) 1
2 45 M Chest wall Pleomorphic sarcoma, myogenic Pleomorphic sarcoma 
rhabdomyosarcoma
1
3 19 M Leg Pleomorphic cell sarcoma Pleomorphic sarcoma (NOS) 1
4 50 F Chest wall Pleomorphic Sarcoma vs poorly differentiated 
carcinoma
NK 3
5 37 F Thigh Pleomorphic cell sarcoma Osteosarcoma 1
6 9 F Arm Pleomorphic cell sarcoma Osteosarcoma 1
7 19 M Leg Pleomorphic cell sarcoma; Osteosarcoma Osteosarcoma 1
8 33 M Forearm Pleomorphic rhabdomyosarcoma Pleomorphic 
rhabdomyosarcoma
1
9 39 M Temporal region Pleomorphic cell sarcoma Pleomorphic liposarcoma 1
10 55 M Retroperitoneum Pleomorphic cell sarcoma NK 3
11 60 F Inguinal Pleomorphic cell sarcoma Pleomorphic sarcoma (NOS) 1
12 50 M Chest wall Pleomorphic cell sarcoma Pleomorphic sarcoma (NOS) 1
Key: Concordance: 1: Concordant; 2: Not specified; 3: Couldn't be ascertained; 4: Discordant M: Male, F: FemaleCytoJournal 2007, 4:20 http://www.cytojournal.com/content/4/1/20
Page 9 of 10
(page number not for citation purposes)
observed between epithelioid and round cell type;
between spindle cell and polygonal type in case of
melanoma of soft parts, as well as between pleomorphic
and lipomatous group in 2 pleomorphic liposarcomas.
Nonetheless, cytomorphological categorization helped in
building up an algorithmic approach towards exact sub
typing.
While Costa et al [31] achieved 20.9% rates in terms of
exact sub typing of sarcomas, we, like Nagira et al [11],
observed an overall higher rate. In their review, Kilpatrick
et al [4] have presented a range of 21–74% of exact sub
typing of sarcomas, based on various studies. Exact sub
typing can be increased with application of ICC [13]. In
the present study, routine ICC was attempted in limited
cases; mostly of the round cell type, as exact sub typing in
these cases has a definite bearing on management. Maxi-
mum cases that lacked exact sub typing were of the spin-
dle cell type. Thirteen cases were diagnosed as spindle cell
sarcomas, even on histology. The reasons in many of these
included referral cases with lack of paraffin blocks and
negativity of a specific lineage, even with IHC, in the
remaining few. Exact sub typing of spindle cell tumors is
a limiting factor, even in other studies [9]. Prognostica-
tion of soft tissue sarcomas has been recommended with
histological grading and staging [32]. Recent studies
[33,34] on cytomorphology of leiomyosarcomas and neu-
rogenic tumors constitute an 'add-on' to refining the exist-
ing cytomorphology of these subtypes.
Apart from its primary diagnosis; the role of FNAC is rec-
ognized in metastatic STT evaluation [7,8]. Evaluation of
'foreign cells' in metastatic locations, in cases with known
clinical context, is less challenging than in situations ini-
tial metastatic presentations. In such cases, clinical details
are imperative before ascertaining a diagnosis. In our
series, out of 28 cases with metastatic lesions, maximum
metastatic deposits were reported in lymph nodes
(55.1%), 'more-so' of the groin, followed by liver and
lungs. While lymph nodes have been observed as the
commonest metastatic location in earlier studies [7,8], in
our study, groin nodes, were found to be more commonly
involved. This might be as a result of more STS occurring
in extremities. While maximum metastatic cases were of
spindle cell type (considering their higher absolute
number), the percentage was highest with epithelioid
tumors. This is because of tendency of sarcomas, with epi-
thelioid morphology, to have increased chances for
metastasis, like carcinomas. An earlier series observed
RMS as the commonest metastasizing tumor [8]. In terms
of exact subtypes, RMS was the commonly metastasizing
tumor in our series.
To sum up, FNAC has a definite role in the diagnosis of
STTs in primary, recurrent and metastatic lesions, for a
timely management. Cytological categorization is effec-
tive, especially for sorting out round cell and pleomorphic
tumors. Spindle and epithelioid cell tumors are challeng-
ing, especially in terms of exact sub typing. Exact sub tying
can be enhanced with applications of ICC. Recognition of
'pitfall' lesions like aggressive fibromatosis is vital. Further
scope of STT evaluation on cytology can be increased with
more studies dealing with application of ancillary tech-
niques on aspirate samples.
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